Gracell Biotechnologies Inc (DELISTED) (GRCL:DL)
10.25
0.00 (0.00%)
USD |
NASDAQ |
Feb 22, 16:00
Gracell Biotechnologies Total Assets (Quarterly): 259.03M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 259.03M |
| June 30, 2023 | 189.95M |
| March 31, 2023 | 214.13M |
| December 31, 2022 | 240.06M |
| September 30, 2022 | 257.98M |
| June 30, 2022 | 283.38M |
| March 31, 2022 | 304.08M |
| Date | Value |
|---|---|
| December 31, 2021 | 323.20M |
| September 30, 2021 | 339.46M |
| June 30, 2021 | 354.49M |
| March 31, 2021 | 362.82M |
| December 31, 2020 | 147.70M |
| September 30, 2020 | 49.90M |
| December 31, 2019 | 58.91M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
49.90M
Minimum
Sep 2020
362.82M
Maximum
Mar 2021
241.79M
Average
258.51M
Median
Total Assets (Quarterly) Benchmarks
| RayzeBio inc (DELISTED) | 603.51M |
| Zai Lab Ltd | 988.44M |
| WuXi Biologics (Cayman) Inc | 7.981B |
| Axonics Inc | 715.56M |
| I-MAB | 368.62M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.85M |
| Shareholders Equity (Quarterly) | 222.18M |